Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate
- PMID: 12730801
- DOI: 10.1007/s00198-002-1344-5
Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate
Abstract
Strontium ranelate (SR) is currently being developed for the treatment of osteoporosis. Pharmacologic studies in animal models have shown that its efficacy on bone mass is based on its original mode of action on bone formation and bone resorption. In normal mice, SR increased bone formation and vertebral bone mass. In normal rats, SR increased bone mass and the mechanical properties of vertebral, humeral and femoral bones, associated with increased femoral shaft diameter. Vertebral bone mineral density and bone strength were also increased by SR, whereas stiffness was not altered, underlining that the improvement in bone strength occurs without inducing defective bone mineralization. In normal adult monkey alveolar bone, SR decreased bone resorption and increased bone. In ovariectomized (OVX) rats, SR limited the reduction in bone mineral content and the decrease in trabecular bone volume induced by estrogen deficiency, by inhibiting bone resorption while maintaining bone formation. Curative treatment with SR also partially restored bone mass in OVX rats. In the model of hind limb immobilization in rats, SR reduced bone resorption and partially limited long bone loss, as assessed by bone mineral content, bone volume, and histomorphometric and biochemical indices of bone resorption. The unique mode of action of SR on bone formation and resorption is also supported by in vitro studies. In calvaria culture systems and osteoblastic cell cultures, SR enhanced the replication of preosteoblastic cells and consequently increased collagen synthesis. Moreover, SR inhibited the bone-resorbing activity of isolated mouse osteoclasts and devreased osteoclast differentiation markers in chicken bone marrow cultures. Altogether, these pharmacologic results suggest that SR optimizes bone metabolism by decreasing bone resorption and promoting bone formation, which may be of potential value in the treatment of osteoporosis.
Similar articles
-
Strontium ranelate: a novel mode of action optimizing bone formation and resorption.Osteoporos Int. 2005 Jan;16 Suppl 1:S7-10. doi: 10.1007/s00198-004-1753-8. Osteoporos Int. 2005. PMID: 15578159 Review.
-
Strontium ranelate in osteoporosis.Curr Pharm Des. 2002;8(21):1907-16. doi: 10.2174/1381612023393639. Curr Pharm Des. 2002. PMID: 12171530 Review.
-
Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.Curr Opin Rheumatol. 2006 Jun;18 Suppl 1:S11-5. doi: 10.1097/01.bor.0000229522.89546.7b. Curr Opin Rheumatol. 2006. PMID: 16735840
-
Strontium ranelate: a physiological approach for optimizing bone formation and resorption.Bone. 2006 Feb;38(2 Suppl 1):S10-4. doi: 10.1016/j.bone.2005.07.029. Epub 2006 Jan 24. Bone. 2006. PMID: 16439191 Review.
-
[Strontium ranelate: a novel concept for the treatment of osteoporosis].Wien Klin Wochenschr. 2005 Nov;117(21-22):728-38. doi: 10.1007/s00508-005-0471-3. Wien Klin Wochenschr. 2005. PMID: 16416353 Review. German.
Cited by
-
[Effects of strontium ranelate on the rats' palatal suture after rapid maxillary expansion].Hua Xi Kou Qiang Yi Xue Za Zhi. 2016 Aug 1;34(4):336-340. doi: 10.7518/hxkq.2016.04.003. Hua Xi Kou Qiang Yi Xue Za Zhi. 2016. PMID: 28317347 Free PMC article. Chinese.
-
Osteoblast calcium-sensing receptor has characteristics of ANF/7TM receptors.J Cell Biochem. 2005 Aug 15;95(6):1081-92. doi: 10.1002/jcb.20500. J Cell Biochem. 2005. PMID: 15962313 Free PMC article.
-
Strontium ranelate: a novel mode of action optimizing bone formation and resorption.Osteoporos Int. 2005 Jan;16 Suppl 1:S7-10. doi: 10.1007/s00198-004-1753-8. Osteoporos Int. 2005. PMID: 15578159 Review.
-
Development of Phosphatized Calcium Carbonate Biominerals as Bioactive Bone Graft Substitute Materials, Part II: Functionalization with Antibacterial Silver Ions.J Funct Biomater. 2018 Nov 23;9(4):67. doi: 10.3390/jfb9040067. J Funct Biomater. 2018. PMID: 30477123 Free PMC article.
-
Strontium-doped calcium phosphate and hydroxyapatite granules promote different inflammatory and bone remodelling responses in normal and ovariectomised rats.PLoS One. 2013 Dec 23;8(12):e84932. doi: 10.1371/journal.pone.0084932. eCollection 2013. PLoS One. 2013. PMID: 24376855 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials